These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 4159128)
21. [ON THE PRESENCE OF 3,7,11,15-TETRAMETHYLHEXADECANOIC ACID (PHYTANIC ACID) IN THE CHOLESTEROL ESTERS AND OTHER LIPOID FRACTIONS OF THE ORGANS IN A CASE OF A DISEASE OF UNKNOWN ORIGIN (POSSIBLY HEREDOPATHIA ATACTICA POLYNEURITIFORMIS, REFSUM'S SYNDROME)]. KLENK E; KAHIKE W Hoppe Seylers Z Physiol Chem; 1963; 333():133-9. PubMed ID: 14058273 [No Abstract] [Full Text] [Related]
22. [Polyneuropathies in inborn metabolic disorders: in diabetes mellitus, in Refsum's disease]. Bischoff A Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1012-8. PubMed ID: 77095 [No Abstract] [Full Text] [Related]
23. Separation and characterization of phytanic acid-containing plasmatriglycerides from a patient with Refsum's disease. Laurell S Biochim Biophys Acta; 1968 Jan; 152(1):75-9. PubMed ID: 4171423 [No Abstract] [Full Text] [Related]
24. Inborn errors of metabolism in neurology (Wilson's disease, Refsum's disease and lipidoses). Cumings JN Proc R Soc Med; 1971 Mar; 64(3):313-22. PubMed ID: 4101505 [No Abstract] [Full Text] [Related]
25. [Distribution of phytanic esters among the serum triglycerides of 5 patients with Refsum's syndrome. A study with thin layer chromatography]. Laudat P; Wolf LM Biochim Biophys Acta; 1969 Mar; 176(2):425-8. PubMed ID: 4180409 [No Abstract] [Full Text] [Related]
26. The nature of the metabolic defect in Refsum's disease. Steinberg D; Avigan J; Mize CE; Herndon JH; Fales HM; Milne GW Pathol Eur; 1968; 3(2):450-8. PubMed ID: 4176998 [No Abstract] [Full Text] [Related]
33. [Pauci-symptomatic sensory polyneuropathy in Refsum's disease]. Lévy R; Verny M; Brault JL; Gugenheim M; Maisonobe T; Léger JM Rev Neurol (Paris); 1996; 152(6-7):469-72. PubMed ID: 8944245 [TBL] [Abstract][Full Text] [Related]
34. [Refsum disease]. Bernscherer G; Berényi E; Karabélyos C; László A; Dávid Z; Hollódy K; Tóth EZ Orv Hetil; 2000 Jan; 141(1):31-4. PubMed ID: 10673856 [TBL] [Abstract][Full Text] [Related]
35. Oxidation of phytanic acid as related to Refsum's disease. Tsai SC N Y State J Med; 1969 Dec; 69(24):3149-52. PubMed ID: 4187656 [No Abstract] [Full Text] [Related]
36. Heredopathia atactica polyneuritiformis (Refsum's Disease): a second trial of dietary therapy in two patients. Kark RA; Engel WK; Blass JP; Steinberg D; Walsh GO Birth Defects Orig Artic Ser; 1971 Feb; 7(1):53-5. PubMed ID: 4141911 [TBL] [Abstract][Full Text] [Related]
37. Identification of genetic heterogeneity in Refsum's disease. Wierzbicki AS; Mitchell J; Lambert-Hammill M; Hancock M; Greenwood J; Sidey MC; de Belleroche J; Gibberd FB Eur J Hum Genet; 2000 Aug; 8(8):649-51. PubMed ID: 10951529 [TBL] [Abstract][Full Text] [Related]
38. Different ratios of the LDD and DDD diastereoisomers of phytanic acid in patients with Refsum's disease. Eldjarn L; Try K Biochim Biophys Acta; 1968 Sep; 164(1):94-100. PubMed ID: 4176022 [No Abstract] [Full Text] [Related]
39. The stereochemistry of phytanic acid in Refsum's syndrome. Lough AK Lipids; 1970 Feb; 5(2):201-3. PubMed ID: 4191055 [No Abstract] [Full Text] [Related]